Jpmorgan Chase & CO Rx Sight, Inc. Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
A detailed history of Jpmorgan Chase & CO transactions in Rx Sight, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 310,960 shares of RXST stock, worth $18.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
310,960
Previous 596,540
47.87%
Holding current value
$18.2 Million
Previous $24.1 Million
33.32%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding RXST
# of Institutions
199Shares Held
25.6MCall Options Held
67KPut Options Held
2K-
Black Rock Inc. New York, NY2.11MShares$123 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.9MShares$111 Million0.15% of portfolio
-
Lord, Abbett & Co. LLC Jersey City, NJ1.77MShares$104 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.52MShares$89.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.13MShares$65.8 Million0.0% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $1.62B
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...